G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 4.34 HKD -2.47% Market Closed
Market Cap: 15.2B HKD
Have any thoughts about
Grand Pharmaceutical Group Ltd?
Write Note

Grand Pharmaceutical Group Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Grand Pharmaceutical Group Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
G
Grand Pharmaceutical Group Ltd
HKEX:512
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
SSY Group Ltd
HKEX:2005
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
U
United Laboratories International Holdings Ltd
HKEX:3933
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sino Biopharmaceutical Ltd
HKEX:1177
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Total Other Income
-HK$26.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Total Other Income
$37.3m
CAGR 3-Years
63%
CAGR 5-Years
42%
CAGR 10-Years
N/A
No Stocks Found

Grand Pharmaceutical Group Ltd
Glance View

Market Cap
15.4B HKD
Industry
Pharmaceuticals

Grand Pharmaceutical Group Ltd. engages in the development, manufacture and distribution of pharmaceutical products. The firm is principally engaged in manufacturing and sales of pharmaceutical preparations and medical devices, bio-technology products, nutrition products, specialized pharmaceutical raw materials and other products. The main products of the Company cover the anti-tumor, cardiovascular emergency pharmaceutical products and advanced cerebro-cardiovascular intervention advanced medical devices, anti-virus and anti-infection, respiratory and ear-nose-throat (ENT), bio-health products and specialized pharmaceutical ingredients.

Intrinsic Value
6.32 HKD
Undervaluation 31%
Intrinsic Value
Price
G

See Also

Back to Top